Page last updated: 2024-09-02

kt 5823 and cyclin d1

kt 5823 has been researched along with cyclin d1 in 1 studies

Compound Research Comparison

Studies
(kt 5823)
Trials
(kt 5823)
Recent Studies (post-2010)
(kt 5823)
Studies
(cyclin d1)
Trials
(cyclin d1)
Recent Studies (post-2010) (cyclin d1)
31705910,885705,157

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ren, Y; Weng, G; Wu, L; Yao, X; Zheng, J1

Other Studies

1 other study(ies) available for kt 5823 and cyclin d1

ArticleYear
Essential role of the cGMP/PKG signaling pathway in regulating the proliferation and survival of human renal carcinoma cells.
    International journal of molecular medicine, 2014, Volume: 34, Issue:5

    Topics: Antineoplastic Agents; Apoptosis; beta Catenin; Carbazoles; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Gene Expression Regulation; Humans; JNK Mitogen-Activated Protein Kinases; Phosphodiesterase 5 Inhibitors; Phosphorylation; Signal Transduction; Sp1 Transcription Factor; Sulindac

2014